NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, an established leader in the development of innovative, proven, and trusted weight loss experiences, today announced the Premarket Approval (PMA) ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, a company dedicated to ending obesity, today announced new clinical data on the Allurion Program presented at ObesityWeek® 2021. The Allurion ...

Allurion Technologies (ALUR) has received a new Buy rating, initiated by Jefferies analyst, Matthew Taylor. Matthew Taylor’s Buy rating for Allurion Technologies is grounded in a strong conviction ...

Allurion Technologies (ALUR) announced the presentation of two abstracts at Obesity Week, the annual meeting of The Obesity Society. The first abstract comprises outcomes data from Allurion’s largest ...

Hello, and welcome to the Allurion Third Quarter Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer ...

Allurion Technologies, Inc. (ALUR) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of a loss of $1.53 per share. This compares to earnings of $2.75 per share ...

Add Yahoo as a preferred source to see more of our stories on Google. If weight loss with drugs that must be self-injected weekly doesn't sound appealing — think Ozempic, Wegovy and Zepbound — there ...

Allurion Technologies (NYSE:ALUR) shares are moving higher Friday, potentially in response to the company's Thursday announcement of a planned clinical study to evaluate the combination of its ...

Allurion Technologies Inc. (NYSE:ALUR) shares soared 10.9% in premarket trading Tuesday after the metabolic health company announced major progress in its U.S. regulatory process and a debt exchange ...

Earnings call Allurion reported Q3 2025 revenue of $2.7M, down 50% YoY due to strategic restructuring but with operating expenses reduced by 29% and adjusted operating loss narrowed by 39%. Management ...

Allurion shares slipped after it priced a discounted warrant exercise expected to raise about $3 million and add potential dilution. Allurion Technologies (NYSE: ALUR) shares are moving higher Friday ...